Drug intelligence / Profile preview

trimethoprim

Development stage
Approved
Modality
Small Molecules
01

Overview

Trimethoprim is a synthetic antibacterial agent primarily used to treat urinary tract infections and other bacterial infections such as otitis media and traveler's diarrhea. It is also used in combination with other drugs (notably sulfamethoxazole) for the treatment of Pneumocystis jirovecii pneumonia in immunocompromised patients. Trimethoprim acts by selectively inhibiting bacterial dihydrofolate reductase, an enzyme essential for folic acid synthesis in bacteria. This inhibition blocks the reduction of dihydrofolic acid to tetrahydrofolic acid, thereby interfering with thymidine synthesis and ultimately inhibiting bacterial DNA replication and cell division. Its selectivity for the bacterial enzyme over the human counterpart makes it effective as an antibiotic[1][2][5].

Brand names
ProloprimMonotrimTriprimPrimsolTrimpex
Other names
甲氧苄啶2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidineTrimetoprim
02

Targets

DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on trimethoprim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trimethoprim.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call